Pump-driven continuous duodenal administration of levodopa - A new therapy for patients with advanced Parkinson's disease;Pumpengesteuerte, kontinuierliche duodenale Levodopa-Gabe - Eine neue therapieoption für patienten mit fortgeschrittenem morbus Parkinson

Psychopharmakotherapie

Volumn 12, Issue 6, 2005, Pages 223-228

  Odin, Per ^a,b   Rüssmann, Anne ^a,b   Aquilonius, Sten Magnus ^a,c  

^a Klinikum Bremerhaven Reinkenheide ^*

^b Neurologische Klinik   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Infusion; Levodopa; Motor fluctuations; Parkinson's disease; Pharmacokinetics

Indexed keywords

APOMORPHINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE; DOPAMINE RECEPTOR; DUODOPA;

BRAIN DEPTH STIMULATION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; GEL; HUMAN; PARKINSON DISEASE; PUMP; REVIEW; STOMACH EMPTYING;

EID: 29544434574     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Nyholm D, Aquilonius SM. Levodopa infusion therapy in Parkinson disease: state of the art in 2004. Clin Neuropharmacol 2004;27:245-56.
2. Movement Disorder Society. Management of Parkinson's disease: an evidence-based review. Mov Disord 2002;17:S1-166.
3. Quinn N, Marsden CD, Parkes JD. Complicated response fluctuations in Parkinson's disease: response to intravenous infusion of levodopa. Lancet 1982;2:412-5.
4. Shoulson I, Glaubiger GA, Chase TN. On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology 1975;25:1144-8.
5. Kurlan R, Rubin AJ, Miller C, Rivera-Calimlim L, et al. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol 1986;20:262-5.
6. Syed N, Murphy J, Zimmerman T Jr, Mark MH, et al. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease. Mov Disord 1998;13:336-8.
7. Nilsson D, Nyholm D, Aquilonius SM. Duodenal levodopa infusion in Parkinson's disease - long-term experience. Acta Neurol Scand 2001;104:343-8.
8. Nyholm D, Askmark H, Gomes-Trolin C, Knutson T, et al. Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets. Clin Neuropharmacol 2003;26:156-63.
9. Stocchi F, Bonamartini A, Vacca L, Ruggieri S. Motor fluctuations in levodopa treatment: clinical pharmacology. Eur Neurol 1996;36(Suppl 1):38-42.
10. Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, et al. Duodenal levodopa infusion monotherapy vs. oral polypharmacy in advanced Parkinson disease. Neurology 2005;64:216-23.
11. Hagell P, Odin P. Apomorphine in the treatment of Parkinson's disease. J Neurosci Nurs 2001;33:21-34, 37-8.
12. Volkmann J. Deep brain stimulation for the treatment of Parkinson's disease. J Clin Neurophysiol 2004;21:6-17.
13. Hariz MI. Complications of deep brain stimulation surgery. Mov Disord 2002;17(Suppl 3):S162-6.